Conmed Corp.
NYSE:CNMD
Other Pre-Announcement
Conmed Corporation Announces Q4 And Full-Year 2022 Financial Results
Published: 02/02/2023 22:05 GMT
Conmed Corp. (CNMD) - Oration Announces Fourth Quarter and Full-year 2022 Financial Results.
Qtrly Sales $250.9 Million Decreased 8.4% Year Over Year As Reported.
Qtrly EPS $0.86.
Qtrly Adjusted Earnings per Share$0.42.
Expects Full-year 2023 Reported Revenue Between $1.170 Billion and $1.220 Billion.
Sees 2023 Adjusted Net Earnings per Share in Range of $3.20 to $3.45.
FY2023 Earnings per Share View $3.37, Revenue View $1.21 Billion -- Refinitiv Ibes Data (analyst estimates).
Q4 Earnings per Share View $0.90, Revenue View $302.5 Million -- Refinitiv Ibes Data (analyst estimates).
Qtrly Sales $250.9 Million Decreased 8.4% Year Over Year As Reported.
Qtrly EPS $0.86.
Qtrly Adjusted Earnings per Share$0.42.
Expects Full-year 2023 Reported Revenue Between $1.170 Billion and $1.220 Billion.
Sees 2023 Adjusted Net Earnings per Share in Range of $3.20 to $3.45.
FY2023 Earnings per Share View $3.37, Revenue View $1.21 Billion -- Refinitiv Ibes Data (analyst estimates).
Q4 Earnings per Share View $0.90, Revenue View $302.5 Million -- Refinitiv Ibes Data (analyst estimates).